Sign In
Buy IBEX
IBEX Earnings Calls
| Release date | May 06, 2026 |
| EPS estimate | $0.86 |
| EPS actual | $0.91 |
| EPS Surprise | 6.43% |
| Revenue estimate | 157M |
| Revenue actual | 164.407M |
| Revenue Surprise | 4.72% |
| Release date | Feb 05, 2026 |
| EPS estimate | $0.785 |
| EPS actual | $0.87 |
| EPS Surprise | 10.83% |
| Revenue estimate | 157M |
| Revenue actual | 164.221M |
| Revenue Surprise | 4.60% |
| Release date | Nov 06, 2025 |
| EPS estimate | $0.81 |
| EPS actual | $0.90 |
| EPS Surprise | 11.11% |
| Revenue estimate | 155.579M |
| Revenue actual | 151.179M |
| Revenue Surprise | -2.83% |
| Release date | Sep 11, 2025 |
| EPS estimate | $0.735 |
| EPS actual | $0.87 |
| EPS Surprise | 18.37% |
| Revenue estimate | 144.617M |
| Revenue actual | 147.138M |
| Revenue Surprise | 1.74% |
Last 4 Quarters for IBEX
Below you can see how IBEX performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
| Release date | Sep 11, 2025 |
| Price on release | $30.46 |
| EPS estimate | $0.735 |
| EPS actual | $0.87 |
| EPS surprise | 18.37% |
| Date | Price |
|---|---|
| Sep 05, 2025 | $29.36 |
| Sep 08, 2025 | $29.63 |
| Sep 09, 2025 | $29.33 |
| Sep 10, 2025 | $28.92 |
| Sep 11, 2025 | $30.46 |
| Sep 12, 2025 | $41.58 |
| Sep 15, 2025 | $38.85 |
| Sep 16, 2025 | $38.89 |
| Sep 17, 2025 | $40.37 |
| 4 days before | 3.75% |
| 4 days after | 32.53% |
| On release day | 36.51% |
| Change in period | 37.50% |
| Release date | Nov 06, 2025 |
| Price on release | $36.86 |
| EPS estimate | $0.81 |
| EPS actual | $0.90 |
| EPS surprise | 11.11% |
| Date | Price |
|---|---|
| Oct 31, 2025 | $37.37 |
| Nov 03, 2025 | $37.98 |
| Nov 04, 2025 | $36.47 |
| Nov 05, 2025 | $37.42 |
| Nov 06, 2025 | $36.86 |
| Nov 07, 2025 | $36.85 |
| Nov 10, 2025 | $36.49 |
| Nov 11, 2025 | $36.61 |
| Nov 12, 2025 | $36.80 |
| 4 days before | -1.36% |
| 4 days after | -0.163% |
| On release day | -0.0271% |
| Change in period | -1.53% |
| Release date | Feb 05, 2026 |
| Price on release | $34.21 |
| EPS estimate | $0.785 |
| EPS actual | $0.87 |
| EPS surprise | 10.83% |
| Date | Price |
|---|---|
| Jan 30, 2026 | $37.20 |
| Feb 02, 2026 | $38.02 |
| Feb 03, 2026 | $34.74 |
| Feb 04, 2026 | $34.47 |
| Feb 05, 2026 | $34.21 |
| Feb 06, 2026 | $34.98 |
| Feb 09, 2026 | $32.82 |
| Feb 10, 2026 | $31.13 |
| Feb 11, 2026 | $30.17 |
| 4 days before | -8.04% |
| 4 days after | -11.81% |
| On release day | 2.25% |
| Change in period | -18.90% |
| Release date | May 06, 2026 |
| Price on release | $28.11 |
| EPS estimate | $0.86 |
| EPS actual | $0.91 |
| EPS surprise | 6.43% |
| Date | Price |
|---|---|
| Apr 30, 2026 | $27.75 |
| May 01, 2026 | $28.25 |
| May 04, 2026 | $27.91 |
| May 05, 2026 | $28.35 |
| May 06, 2026 | $28.11 |
| May 07, 2026 | $32.76 |
| May 08, 2026 | $32.33 |
| May 11, 2026 | $32.57 |
| May 12, 2026 | $31.02 |
| 4 days before | 1.30% |
| 4 days after | 10.35% |
| On release day | 16.54% |
| Change in period | 11.78% |
IBEX Earnings Call Transcript Summary of Q1 2026
IBEX reported a strong start to FY2026 with revenue of $151.2M, up 16.5% year-over-year, and record first-quarter adjusted EBITDA, adjusted EPS and free cash flow. Adjusted EPS rose 74% to $0.90 and adjusted EBITDA increased 24.9% to $19.5M (12.9% margin). Growth was broad-based across retail & e-commerce, HealthTech and travel/transportation; fintech returned to growth and telecom declined as expected. High-margin offshore and digital/omnichannel services continue to expand (offshore revenue +20% in the quarter; digital/omnichannel now ~82% of revenue). Cash generation improved (operating cash $15.7M, FCF $8M), DSOs improved, and the company repurchased shares ($2.7M in the quarter) with $10.6M remaining on the program. Management emphasized AI as a differentiator—internal AI tools and client-facing AI + human agent integration—and expects AI deployments to become a more meaningful growth and margin lever by late FY2026/FY2027. Fiscal 2026 guidance was raised: revenue $605M–$620M (from $590M–$610M) and adjusted EBITDA $78M–$81M (from $75M–$79M); CapEx expected $20M–$25M. Operational resilience in the face of natural disasters (notably Hurricane Melissa in Jamaica) and strong client retention (>98%) were highlighted as competitive strengths.
